Screener
Insight Molecular Diagnostics Inc. IMDX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Insight Molecular Diagnostics Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Insight Molecular Diagnostics Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001642380-26-000011
FAQ
- What is Insight Molecular Diagnostics Inc.'s net income?
- Insight Molecular Diagnostics Inc. (IMDX) reported net income of -$11.26M in Q2 2026.
- How has Insight Molecular Diagnostics Inc.'s net income changed year-over-year?
- Insight Molecular Diagnostics Inc.'s net income decreased by 15.6% year-over-year, from -$9.74M to -$11.26M.
- What is the long-term trend for Insight Molecular Diagnostics Inc.'s net income?
- Over 4 years (2021 to 2025), Insight Molecular Diagnostics Inc.'s net income has grown at a -5.9% compound annual growth rate (CAGR), from -$64.1M to -$50.22M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Insight Molecular Diagnostics Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude